MIRATI THERAPEUTICS, INC. Selling, General and Administrative Expense
MIRATI THERAPEUTICS, INC. reported Selling, General and Administrative Expense of $72.00 million for the 3-month period ending 2023-09-30, per its 10-Q filed 2023-11-06.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2023-11-06
- MIRATI THERAPEUTICS, INC. selling, general and administrative expense for the quarter ending 2023-09-30 was $72.00M, a 18.43% increase year-over-year.
- MIRATI THERAPEUTICS, INC. selling, general and administrative expense for the quarter ending 2023-06-30 was $75.49M, a 39.21% increase year-over-year.
- MIRATI THERAPEUTICS, INC. selling, general and administrative expense for the quarter ending 2023-03-31 was $73.49M, a 36.22% increase year-over-year.
- MIRATI THERAPEUTICS, INC. selling, general and administrative expense for the quarter ending 2022-12-31 was $70.82M.
- MIRATI THERAPEUTICS, INC. selling, general and administrative expense for fiscal 2022 was $239.80M, a 75.45% increase from fiscal 2021.
- MIRATI THERAPEUTICS, INC. selling, general and administrative expense for fiscal 2021 was $136.68M, a 63.86% increase from fiscal 2020.
- MIRATI THERAPEUTICS, INC. selling, general and administrative expense for fiscal 2020 was $83.41M.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 9 month | Selling, General and Administrative Expense 12 month |
|---|---|---|---|---|
| 2023-09-30 | $72.00M 10-Q · filed 2023-11-06 | $147.49M derived: sum of 2 quarters · filed 2023-11-06 | $220.98M 10-Q · filed 2023-11-06 | $291.80M derived: sum of 4 quarters · filed 2023-11-06 |
| 2023-06-30 | $75.49M 10-Q · filed 2023-08-08 | $148.98M 10-Q · filed 2023-08-08 | $219.80M derived: sum of 3 quarters · filed 2023-08-08 | $280.60M derived: sum of 4 quarters · filed 2023-11-06 |
| 2023-03-31 | $73.49M 10-Q · filed 2023-05-09 | $144.31M derived: sum of 2 quarters · filed 2023-05-09 | $205.11M derived: sum of 3 quarters · filed 2023-11-06 | $259.34M derived: sum of 4 quarters · filed 2023-11-06 |
| 2022-12-31 | $70.82M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $131.62M derived: sum of 2 quarters · filed 2023-11-06 | $185.85M derived: sum of 3 quarters · filed 2023-11-06 | $239.80M 10-K · filed 2023-02-28 |
| 2022-09-30 | $60.80M 10-Q · filed 2023-11-06 | $115.03M derived: sum of 2 quarters · filed 2023-11-06 | $168.98M 10-Q · filed 2023-11-06 | |
| 2022-06-30 | $54.23M 10-Q · filed 2023-08-08 | $108.18M 10-Q · filed 2023-08-08 | ||
| 2022-03-31 | $53.95M 10-Q · filed 2023-05-09 | |||
| 2021-12-31 | $136.68M 10-K · filed 2023-02-28 | |||
| 2020-12-31 | $83.41M 10-K · filed 2023-02-28 |